Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007–16

on behalf of the Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)

Abstract

Objectives: To compare the epidemiology and antimicrobial susceptibility patterns of Streptococcus pneumoniae collected from respiratory and blood culture samples in Canada between 2007 and 2016. Methods: S. pneumoniae strains were obtained from Canadian hospitals as part of the ongoing national surveillance study, CANWARD. Isolates were serotyped using the Quellung method. Antimicrobial susceptibility testing was performed using the CLSI broth microdilution method. MDR and XDR were defined as resistance to three or more and five or more classes of antimicrobials, respectively. Results: Of the 2581 S. pneumoniae isolates collected, 1685 (65.3%) and 896 (34.7%) were obtained from respiratory and blood samples, respectively. Respiratory isolates demonstrated lower rates of antimicrobial susceptibility than blood isolates to penicillin, ceftriaxone, clarithromycin, clindamycin, doxycycline and trimethoprim/sulfamethoxazole (P≤0.03). From 2007 to 2016, invasive isolates demonstrated trends towards increasing penicillin susceptibility and decreasing clarithromycin susceptibility. MDR was significantly higher in respiratory S. pneumoniae compared with blood (9.1% versus 4.5%, P,0.0001). Serotypes 11A, 16F, 19F, 23A/B/F, 34, 35B and non-typeable strains were more commonly isolated from respiratory specimens, while 4, 5, 7F, 8, 12F, 14 and 19A were more commonly invasive serotypes. Numerous serotypes, including 3 and 22F, were isolated frequently from both specimen sources. Conclusions: S. pneumoniae from respiratory samples demonstrated lower antimicrobial susceptibilities and higher MDR in a greater diversity of serotypes than isolates obtained from blood. Many serotypes were associated with one specific specimen source, while others were associated with both; genetic characterization is necessary to elucidate the specific factors influencing the ability of these serotypes to commonly cause both invasive and non-invasive disease.

Original languageEnglish
Pages (from-to)IV39-IV47
JournalJournal of Antimicrobial Chemotherapy
Volume74
DOIs
Publication statusPublished - Apr 1 2019

Bibliographical note

Funding Information:
The data in this paper were previously presented in part at the ASM Microbe 2017 meeting, 1–5 June 2017 in New Orleans, LA (poster number Friday-142). CANWARD data can also be found at www.can-r.ca, the official website of CARA. We thank the Public Health Agency of Canada- National Microbiology Laboratory (PHAC-NML) and the members of CARA for their efforts and support of this project. The CANWARD study was supported in part by the University of Manitoba, Diagnostic Services – Shared Health Manitoba, the National Microbiology Laboratory, Astellas, Merck, Pfizer, Sunovion, The Medicines Company, Abbott, Achaogen, Cubist, Paladin Labs, Bayer, Janssen Ortho/ Ortho McNeil, Affinium, Basilea, AstraZeneca, Paratek, Tetraphase, Theravance, Sanofi-Aventis and Zoetis.

Publisher Copyright:
© The Author(s) 2019.

ASJC Scopus Subject Areas

  • Pharmacology
  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007–16'. Together they form a unique fingerprint.

Cite this